About Liberate Bio
Liberate Bio develops non-viral delivery technologies for nucleic acid cargoes, aiming to address genetic disorders.
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Seed
Global Headquarters
Boston, United States
Tracked Since
Nov 8, 2026
Web & Domain Identity
Official Website
liberatebio.com
Domain Registered Date
Undisclosed
Social & Network Presence
X / Twitter Profile
Not linked
LinkedIn Corporate
Company Profile
Company Milestones & Timeline
- Capital Raise
Raised $31,000,000 · Seed
fundraisingfox.com
Investors & Backers
Khosla Ventures
Funding History
Seed equity
· Oct 15, 2025
$31,000,000 fundraisingfox.com
Founders & Leadership
Michael Mitchell
CO-FOUNDER, UNIVERSITY OF PENNSYLVANIA
Work email & phone locked
Unlock →
Nessan Bermingham
CO-FOUNDER, KHOSLA VENTURES
Work email & phone locked
Unlock →
Shawn Davis
Chief Executive Officer
Work email & phone locked
Unlock →
Stephen Scully
Founder
Work email & phone locked
Unlock →
Steven Bernstein
Chief Medical Officer
Work email & phone locked
Unlock →
Theresa M. Reineke
CO-FOUNDER, UNIVERSITY OF MINNESOTA
Work email & phone locked
Unlock →
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allTesorai
tesorai.com
Seed Nov 2026
Commit Biologics
commitbio.com
Seed Aarhus · Nov 2026
Human Biome
human-biome.com
Series-A Warsaw · Nov 2026
MedInTech
medintech.co.kr
Series-B Seoul · Nov 2026
Ace Padel
acepadel.com
Seed Bradenton, United States · Nov 2026
Mentix
mentix.world
Pre-Seed London, United Kingdom · Nov 2026